GlassScriptPhysician profile
Taryn Joyce
NPI 1235787235
$3,817.45
in general payments reported to CMS, 2019-2025
14 companies · $1,925 in 2025
The $1,925 reported for 2025 was more than what 95% of Psychiatric/Mental Health, Adult (Registered Nurse) providers received nationally (typical 2025 total: $121).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $141 · 2023: $918 · 2024: $834 · 2025: $1,925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,676.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $994.51 | 2023-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $642.33 | 2022-2025 | Caplyta |
| Abbvie INC. | $517.31 | 2023-2025 | |
| Vanda Pharmaceuticals INC. | $412.62 | 2024-2025 | Fanapt |
| Teva Pharmaceuticals USA, INC. | $390.48 | 2023-2025 | Uzedy, Austedo Xr |
| Janssen Pharmaceuticals, INC | $329.32 | 2022-2025 | Spravato, Invega Sustenna, Invega Trinza |
| Alkermes, INC. | $150.90 | 2024-2025 | Lybalvi, Aristada |
| Regeneron Healthcare Solutions, INC. | $121.83 | 2024 | Libtayo |
| Axsome Therapeutics, INC. | $85.30 | 2024-2025 | Auvelity |
| Neurocrine Biosciences, INC. | $56.19 | 2024-2025 | Ingrezza |
| Corium, LLC | $54.57 | 2025 | Azstarys |
| Tris Pharma INC | $28.89 | 2025 | Dyanavel Xr |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $18.29 | 2023 | |
| Lundbeck LLC | $14.91 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taryn Joyce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.